0000914475-24-000191.txt : 20240815 0000914475-24-000191.hdr.sgml : 20240815 20240815170601 ACCESSION NUMBER: 0000914475-24-000191 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240813 FILED AS OF DATE: 20240815 DATE AS OF CHANGE: 20240815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Delaet Ingrid CENTRAL INDEX KEY: 0001965808 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 241213316 MAIL ADDRESS: STREET 1: C/O NEUROCRINE BIOSCIENCES, INC. STREET 2: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330525145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6027 EDGEWOOD BEND COURT CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 wk-form4_1723755955.xml FORM 4 X0508 4 2024-08-13 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001965808 Delaet Ingrid 12780 EL CAMINO REAL SAN DIEGO CA 92130 0 1 0 0 Chief Regulatory Officer 1 Common Stock 2024-08-13 4 M 0 3043 103.52 A 9650 D Common Stock 2024-08-13 4 S 0 3043 150.1305 D 6607 D Common Stock 2024-08-13 4 S 0 4100 150.0813 D 2507 D Non-Qualified Stock Option 103.52 2024-08-13 4 M 0 3043 0 D 2033-02-13 Common Stock 3043 22049 D The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.44. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.28. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. /s/ Darin Lippoldt, Attorney-in-Fact 2024-08-15